Finlepsin® retard (Finlepsin® retard)

Maka nke a ọgwụ mgbochisitere na usoro dibenzazepinebu kwa agwa antidepressant, antipsychotic, antidiuretic na analgesicmmetụta. Ihe omume nke ogwu a nwere na mgbochi. voltaji-gated sodium ọwa, na-atụnye aka na nkwụsi ike nke membranes nke oké neurons, belata synaptik ụzọ nke mkpali na inhibition nke Ogwe aka mwepu nke neurons. Mwepụta nke amino acid neurotransmitter belatara - afọ nrina-enwe mmetụta na-atọ ụtọ, nke na-enyere aka belata mbata ọnụ nke sistemụ ụjọ, yana, n'ihi nke a, enwere ike ịnwe oghere ọdịdọ.

A na-egosipụta ịdị irè nke ọgwụ ahụ n'ọrịa ọdịdọ dị mfe ma ọ bụ sie ike, nke enwere ike isoro ya gaa nke abụọ nnweta na ndị ọzọ. N'otu oge ahụ, rịba ama mgbaàmà ama ama ama. ụjọ, ịda mba, iwenaike ike.

Ejiri ogwu a mara nwayọ, ma juputara absorptionnọọrọ onwe ya na iri nri. A na-enweta ntinye uche nke ihe dị na ahụ n'ime awa iri na abụọ na-eji otu ngwa Finlepsin Retard 400 mg, mgbe ị na-edozi ịdị mma ọgwụgwọ nke awa 4-5. N'otu oge ahụ, a na-agbanye n'ọtụtụ nchịkọta nke ihe ndị dị n'ọrụ na plasma mgbe usoro ọgwụgwọ nke izu 1-2 gachara. Agbanyeghị, nke a nwere ike ịdabere na njirimara nke metabolism nke onye ọrịa: ntinye nke sistem enzyme na imeju, inwetara site na ọgwụ ndị ọzọ a na-ewere n'otu oge, ọnọdụ onye ọrịa, usoro onunu ogwu ya na oge ọgwụgwọ. Achọpụtara na carbamazepine na-abanye na mmiri ara ara yana gafere oghere mgbochi.

Ọgwụ metabolism na-eme na imeju ya na imepụta ihe ndị bụ isi metabolites: carbamazepine-10,11-epoxide - conjugate na-adịghị arụ ọrụ acid glucuronic. N'ihi usoro metabolic, etolite metabolism nke 9-hydroxymethyl-10-carbamoylacridane na-arụ ọrụ, nwere ike ịmalite metabolism nke ya. Cchụpụ ọgwụ a tumadi na mmụba mmamịrị, akụkụ ya na feces.

Ihe ngosi Finlepsin

Isi ihe eji egosi Finlepsin:

• ụdị dị iche iche Akwụkwụ na-adọ
• neuralgia
• ihe mgbu na nsogbu ụjọ n’arụ ndị ọrịa ọrịa shuga
• ọnọdụ dị iche iche na - ama jijiji, ihe ọdịdọ, na ihe ndị ọzọ,
• ọrịa mmanya na-egbu egbu,
• nsogbu uche.

Ihe ngbanwe

Edeghị Finlepsin maka:

• hypersensitivity ya ma ọ bụ tricyclic antidepressants,
• nsogbu nke ụmị ọkpụkpụ,
• nnukwu ọnụnọ porfria,
• Ihe mgbochi AV,
• ijikwa nkwadebe lithium ma ọ bụ ndị na-egbochi MAO.

A na-adụ ọdụ ịkpachara anya banyere ọgwụgwọ ndị ọrịa nwere nkụda mmụọ na-adịghị ala ala, ọgbụgba nke hyponatremia, nsogbu imeju na akụrụ, ndị agadi, ị activeụ mmanya na-egbu egbu, mwepu ọnya ụmị ọkpụkpụ, mgbe ị na-a medicationsụ ọgwụ ụfọdụ, hyperplasia prostate, ụba intraocular, na ndị ọzọ.

Nsonaazụ nke finlepsin

Dịka iwu, mmetụta ndị ọzọ na -eme n'oge ọgwụgwọ a nwere ike ịmalite n'ihi oke onunu ogwu ma ọ bụ mgbanwe dị ukwuu na ịta ahụ arụ ọrụ ahụ. N'ọnọdụ ka ukwuu, ihe ndị na-adọpụ uche na sistemụ akwara ozi bụ ihe ama ama: anya ntughari,ataxia, ura, nsogbu adighi, isi ọwụwa na ndị ọzọ. Igosiputa bu ihe puru ime. mmeghachi omume nfụkasị ahụọmụmaatụ urticaria, erythrodermaọnya anụ ahụ na mgbaàmà ndị ọzọ.

Usoro hematopoietic na ọbara nwere ike ịzaghachi site na: leukopenia, thrombocytopenia, eosinophilia, leukocytosis, lymphadenopathy. Ohere inweta ndọpụ iche na ngwara nke diges. ọgbụgbọ, vomiting, akpịrị ịkpọ nkụ, mụbaa ọrụ gamma-glutamyl transferase, ọrụ na hepatic transaminases, afọ ọsịsa ma obu afọ ntachi.

Na mgbakwunye, nsogbu ndị metụtara usoro endocrine na metabolism nwere ike ime: ọzịza, njigide mmiri, ibu dị arọ, vomiting, hyponatremia na ndị ọzọ. Mmeghari akwara na akwara ikari ekwesighi imebi.

Mpempe akwụkwọ Finlepsin, ntuziaka maka ojiji (usoro na usoro onunu ogwu)

Emere ọgwụ a maka nchịkwa ọnụ, n'agbanyeghị nri.

Na ọgwụgwọ Akwụkwụ na-adọ Edere mbadamba ọgwụ dị ka monotherapy. Ọ bụrụ na Finlepsin nwere njikọ antiepileptik, mgbe ahụ, a na-eme nke a nwayọ, na-achịkwa usoro onunu ogwu. N'ọnọdụ ebe ọgwụ pịkọtara ada, a ga-ewererịrị ya ozugbo, ebe enwere ntiwapụ, mana ịgaghị eji ntinye okpukpu abụọ dochie ngafe ahụ.

Dabere na ntuziaka maka ojiji Finlepsin Retard, ndị ọrịa okenye na mbido ọgwụgwọ ka a na-enye usoro ọgwụ kwa ụbọchị nke 200-400 mg. Mgbe ahụ, mmụba nwayọ na usoro onunu ogwu ga-ekwe omume, na-enye ohere iji nweta ezigbo arụmọrụ. Thegwọ mmezi kwa ụbọchị bụ - 800-1200 mg, ebe ekesara ego a na usoro 1-3. Oke kacha anabata kwa ụbọchị ekwesịghị gafere 1.6-2 g.

Maka ụmụaka, usoro ọgwụ a na-adabere na afọ. Na mgbakwunye, mgbe ọ na-esiri nwatakịrị ike ịillụ ọgwụ ọ bụla, ọ ga-ata ata, gwerie ya ma gwerie ya na obere mmiri.

Mụaka 1-5 gbara afọ ka edepụtara 100-200 mg, nke nta nke nta, a na-amụba usoro ọgwụ kwa ụbọchị iji rụpụta ezigbo ọrụ.

6mụaka dị afọ 6-10 ka akwadoro ịmalite iji usoro ọgwụgwọ kwa ụbọchị Finlepsin Retard 200 mg, mgbe ahụkwa, a na-amụba dose ahụ nke nta nke nta.

Usoro ọgwụgwọ kwa ụbọchị maka ụmụaka afọ 11-15 dị 100 mg. Mgbe nke a gasiri jiri nwayọ gbago ya site na 100 mg ruo mgbe egosipụta ezigbo nsonaazụ.

Nkezi mmezi kwa ụbọchị: maka obere ndị ọrịa 1-5 afọ, 200-400 mg, 6-10 afọ ke nso nke 400-600 mg, 11-15 afọ, 600-1000 mg, nke kewara n'ime ọtụtụ usoro.

Ogologo oge ọgwụgwọ ahụ dabere na ngosipụta na njirimara nke onye ọrịa. N'ọnọdụ ọ bụla, mkpebi niile metụtara ọgwụgwọ ka bụ ọrụ nke dibịa. Ọtụtụ mgbe, a na-ekwu okwu banyere iwelata ọgwụ ma ọ bụ ịkwụsị ọgwụ ahụ mgbe onye ọrịa ahụ enweghị ọdịdọ afọ 2-3.

Contkwụsị usoro ọgwụgwọ gụnyere mbelata nke nwayọ nwayọ, afọ 1-2, na-elele EEG mgbe niile. N'okwu a, ụmụaka ga-eburu n'uche ibu na-abawanye ụba na afọ.

N'oge ọgwụgwọ nke nsogbu ndị ọzọ dịka ihe ngosi si gosipụta, dọkịta kpebiri ịsụ ya na oge ole ọ ga-abanye, na-eburu n'uche ọrịa ahụ na otu onye ọrịa ahụ.

Dodoụbiga ya ókè

Site na mmachi nke Finlepsin, ọrịa dị iche iche nwere ike ịmalite, na-egosi imebi akwara, usoro akwara umeji na akụkụ iku ume, akụrụngwa anụ ahụ na ihe ndị ọzọ.

E gosiputara nke a: mmegbu nke usoro ụjọ ahụ, nchegharị, ụjọ ụra, mkparị, ihe atụ, ọgbụgba, ọhụhụ ụzọ, tachycardiaọdịda nke ọbara mgbali, nkụda mmụọ, ọdịda iku ume, akụkụ akwara umeji, ọgbụgbọ, ọgbụgbọ, njigide urinary, na ndị ọzọ.

Emebere ya na ọnweghị ọgwụ mgbochi maka ọgwụgwọ ịdoụbiga mmanya ókè, yabụ, a na-akwado ọgwụgwọ na-enye nkwado dabere na akara ngosi gosipụtara, n'ọnọdụ ndị siri ike - na ọnọdụ ụlọ ọgwụ.

Mmekorita

Nchikota nke ogwu a na Ndị na-egbochi CYP3A4 na-akpata mmụba nke ịta carbamazepine na ihe mejupụtara plasma ọbara na mmepe nke mmeghachi omume ojoo. Njikọ na inducers nke CYP3A4 mgbe ọ na-eme ka metabolism dị elucarbamazepine, na -ebelata ịta ya na nsonaazụ ọgwụgwọ.

N'out oge verapamil, diltiazem, felodipine, dextropropoxyphene, viloxazine, fluoxetine, fluvoxamine, cimetidine, acetazolamide,danazole, desipramine, nicotinamide, ka macrolides - erythromycin, josamycin, clarithromycin, troleandomycin, ụfọdụ nsogbu itraconazole, ketoconazole na fluconazole nwere ike ịbawanye ịta ụta carbamazepinemana. Otu omume bụ njimara nke terfenadine, loratadine, isoniazid, propoxypheneihe ọ juiceụpeụ mkpụrụ osisi vaịn, ndị na-egbochi ya. N'okwu a, ndozi usoro na ịchịkwa itinye uche nke ihe dị na plasma dị mkpa.

Njikọ ọnụ nwere ike ibute ibelata ma ọ bụ nwekwuo mkpokọta. felbamate na carbamazepine.

Concentta obere carbamazepine nwekwara ike: phenobarbital, primidone, metsuximide, phenytoin, fensuximide, theophylline, cisplatin, doxorubicin,rifampicin, clonazepam, valproic acid, valpromide, oxcarbazepine na otutu nkwadebe ahihia nke nwere Hypericum perforatum.

Carbamazepine na-ebelata ọgwụ ịgwọ plasma dịka:clobazam, clonazepam, ethosuximide, primidone, digoxin, valproic acid, alprazolam, cyclosporine, tetracycline, haloperidol,nkwuputa onu nwere estrogen na progesterone na ndị ọzọ.

Ọ guzosiri ike na tetracyclines belata mmetụta ọgwụgwọ ahụ carbamazepine. Jiri na paracetamol na - eme ka ọghọm nsị belata na-adị na imeju, na - ebelata nrụpụta ọgwụgwọ. Njikọ na phenothiazines, pimozide, molindone, clozapine, haloperidol, thioxanthenes, maprotilinena ọgwụ tricyclic antidepressants na-akwalite mmetụta inhibitory na sistem ụjọ, na-ebelata mmetụta anticonvulsant nke ọgwụ.

Ya mere, mgbe enyere ndị ọrịa Finlepsin ọgwụ, ọ dị mkpa ịgwa dọkịta ozugbo ozugbo banyere ọgwụ ha ka na-a takingụ.

Anaakpọ Finlepsin

A na - anọchi anya ọgwụ analogues nke Finlepsin site na ọgwụ: Actinval, Apo-Carbamazepine, Zagretol, Zeptol, Carbalepsin retard, Carbamazepine, Mazepin, Stazepin, Storilat, Tegretolna ndị ọzọ.

Ọ guzosiri ike na carbamazepinena-ebelata nnabata ethanol. Ma ị drinkingụ mmanya n’oge ọrịa a gosipụtara ọgwụ a, anyị nwere ike ịtụ anya mmepe nke mmetụta na nsogbu dị iche iche.

Nyocha maka Finlepsin

N'ọtụtụ oge, ndị ọrụ na-ahapụ nzaghachi banyere Finlepsin Retardnke ha ma ọ bụ ndị ha hụrụ n'anya na-ewere ọtụtụ afọ. Patientsfọdụ ndị ọrịa na-ata ahụhụ Akwụkwụ na-adọ, rịba ama na ị thisụ ọgwụ a na-emetụtaghị ọrụ ọgụgụ isi ha, na-eduga na mmepe nke enweghị mmasị na nkwukọrịta mmekọrịta ọha na eze. Ka o sina dị, n'agbanyeghị akara ndị a, ndị ọrịa na-akwado ịdị oke ọgwụ ahụ, na-enye gị ohere ichefu banyere mwakpo ahụ.

Enwere nyocha mgbe ejiri Finlepsin mee ihe n'ịgwọ mwakpo egwu na-ejikọta ya na egwu nke mepere emepe ma ọ bụ, ọzọ, oghere mechiri emechi. N'ihi ọgwụgwọ, n'ọtụtụ oge, ụjọ ahụ na-apụ n'anya, n'agbanyeghị ụfọdụ, enweghị ike na uru ahụ ka na-eche.

Ya mere, Finlepsin bụ otu n'ime ọgwụ ọgwụ anticonvulsant na antiepileptic na-ejikarị iji rụọ ọrụ ọfụma. Dabere na ndị ọkachamara, iji ọgwụgwọ a rụọ ọrụ na-enye gị ohere inweta nsonaazụ na-enweghị atụ. Isi ihe bụ ịdebe iwu niile dọkịta nyere, gbasara usoro ị theụ ọgwụ na mgbanwe ndụ, ịmata ihe kpatara mbadamba Finlepsin ma were ya naanị dịka ihe egosi.

Ntọhapụ n'ụdị ọgwụ mejupụtara

Finlepsin Retard dị n'ụdị mbadamba maka nchịkwa ọnụ. Mbadamba nkume ndị ahụ na-acha ọcha, gbaa gburugburu, ha nwere ihe egwu dị n'otu akụkụ, ndị juru na blisters nke iberibe 10 (5) na igbe kaadi. Nkọwa nwere nkọwa zuru ezu na ọgwụ a.

Otu mbadamba nke ọ bụla nwere ihe mejupụtara Carbamazepine 200 mg ma ọ bụ 400 mg, yana ọtụtụ ihe inyeaka: microcrystalline cellulose, magnesium stearate, gelatin.

Usoro onunu ogwu na nhazi

Ọ bụ dọkịta ka edoziri ọ̀tụ̀tụ̀ ọgwụ ahụ n’otu n’otu, dabere n’otú akụkụ ahụ onye ọrịa si achọpụta ya.

Ọgwụ mbụ nke ọgwụ maka ndị okenye na ndị ntorobịa karịrị afọ 14 bụ 100-400 mg kwa ụbọchị. Ọ bụrụ na enweghị ọgwụgwọ ọgwụgwọ ma ọ bụ mmetụta na-ezughị ezu n'okpuru nlekọta dọkịta, a na-abawanye ọgwụ ahụ site na 200 mg kwa ụbọchị na oge dị ka izu 1. Dabere na ị dailyụ ọgwụ kwa ụbọchị, a na-eke ọgwụ ahụ ka ọ bụrụ ọgwụ 1-2, ọ na-atụ aro ilo mmiri mbadamba ihe ozugbo.

Maka ụmụaka na-erubeghị afọ isii, a na-agbakọta ọ̀tụ̀tụ̀ ọgwụ ahụ na-adabere n’ihe ngosipụta nke ịdị arọ nke ahụ́ mmadụ - 10 mg / kg kwa ụbọchị, a na-ekewa ihe ọmụmụ ahụ enwetara na usoro 2-3. Aremụaka dị afọ isii rue afọ iri na abụọ ka etinyere ọgwụ ọgwụ mg 200 n ’kwa ụbọchị, a na-ekewa dose ahụ ụzọ abụọ. Ọ bụrụ na mmetụta ezughi oke, mgbe izu 1 gasịrị, ọgwụ ọgwụ ike ga-abawanye site na 100 mg. Oke kachasị maka ụmụaka kwa ụbọchị bụ 1 g, maka ndị okenye - 1200 mg.

Ime na lactation

Enweghị ahụmịhe maka iji ọgwụ maka ọgwụgwọ nke ụmụ nwanyị dị ime na ọkara nke mbụ na nchekwa nke carbamazepine maka nwa ebu n’afọ egosipụtaghị.

Ojiji nke Finlepsin Retard mbadamba n’ime oge nke abụọ na nke atọ nke afọ ime ga-ekwe omume naanị ma ọ bụrụ na enwere ezigbo ihe ngosi, n’ọnọdụ ahụ mgbe uru nne ya ga-aba ga-adị n’iru nwa amụrụ nwa. Enwere ike iji ọgwụ ahụ rụọ ọrụ na ntakịrị oge dị oke mma na ụdị monotherapy.

Mụ nwanyị ndị eji Finlepsin Retard mbadamba mkpụrụ ọgwụ ahụ kwesịrị iji ọgwụ mgbochi dị elu gbochie afọ ime. Ọ bụrụ na ime amalite, mgbe ahụ nwanyị kwesịrị ịkpọtụrụ dọkịta ozugbo ma kwụsị ị .ụ ọgwụ.

Enwere ike ịgbaze carbamazepine na mmiri ara ara, ya mere, ọ bụ ihe na-adịghị mma iji mbadamba Finlepsin Retard na ụmụ nwanyị n'oge a na-enye ara. Ọ bụrụ na ọgwụgwọ dị mkpa, a na-atụ aro ka a na-enye nwa ara ka ọ ghara imerụ nwa ahụ.

Nsonaazụ

Mgbe ị na-ewere mbadamba ihe nrịba ama Finlepsin na ndị ọrịa na-amụbawanye ọgụgụ nke ọgwụ ahụ, mmetụta ndị ọzọ nwere ike ịmalite:

• site na ụjọ usoro - iro ụra, enweghị mmasị n'ihe na - eme, ataxia, dizzness, ọhụụ abụọ, isi ọwụwa, ntinye aka na ụkwụ, nsogbu nke ebe obibi, paresis, hallucinations, neuritis, ike ọgwụgwụ, ịda mba, ahụ erughị ala, nsogbu nke uto na ọkwa nnabata, mkpọtụ na-eti ntị
• site na ngwara nri - glossitis, stomatitis, agụụ belatara, obi mgbawa, ọgbụgbọ, vomiting, ịba ọcha n'anya, mgbu na-abawanye, ọrụ ịba ụba nke ọrịa hepatic transaminases, nsogbu ọnya,
• sitere na akwara gbasara obi - obi mgbakasị ahụ, ngọngọ nke akwara ozi, oke akwara vaskụla, thrombophlebitis, thromboembolism, mmepe nke nkụchi obi,
• site na akụkụ ahụ haemopoietic - mbelata ọnụ ọgụgụ nke leukocytes, platelet, agranulocytosis, anaemia, hemolytic anemia,
• sistem endocrine na metabolism - hyponatremia, ụkwara ume ọrụ akụrụngwa, gynecomastia, galactorrhea, nsị thyroid, cholesterol mụbara, edema, njigide mmiri,
• site na akụkụ urinary - arụ ọrụ na-arụ ọrụ nke akụrụ, nsogbu akụrụ, nsogbu nephritis,
• Mmeghachi omume nfụkasị - ọnya ọnya, itching, lymph nodes, redness nke anụahụ.

Ọ bụrụ na otu ihe ọ bụla na-emetụta ya, onye ọrịa ahụ kwesịrị ịga hụ dọkịta maka ndụmọdụ.

Nhazi ọkwa nosological (ICD-10)

Mlọ ọgwụ

Aborọsọ bụ nwayọ ma zuru oke (iri nri anaghị emetụta oke ọnụego ya na mmiri.) Mgbe otu ọgwụ ogwu pụtasịrị C_max ruru ka elekere 32. Nkezi C_max Ihe na - agbanweghi agbanwe na - eme ihe mgbe ọ bụla otu mgmg nke ọgwụ carbamazepine dị ihe dị ka 2.5 μg / ml. C_ss ọgwụ dị na plasma erutela n’izu 1-2, ọnụego ihe a rụzuru na-adabere n’otu njirimara nke metabolism (ntinye nke sistem enzyme imeju, inwetara site na ọgwụ ndị ọzọ ejiri n’otu oge), yana ọnọdụ onye ọrịa, oke ọgwụ na oge ọgwụgwọ. A na-ahụta ọdịiche dị n'etiti mmadụ na ụkpụrụ C._ss na usoro ọgwụgwọ: n'ọtụtụ ndị ọrịa, ụkpụrụ ndị a sitere na 4 ruo 12 μg / ml (17-50 μmol / l). Ọta nke carbamazepine-10,11-epoxide (metabolite na-arụ ọrụ metabolite) bụ ihe dịka 30% nke ịta ahụhụ nke carbamazepine.

Nkwukọrịta na protein plasma na ụmụaka - 55–59%, na ndị okenye - 70-80%.

Na-ahụ V_d - 0.8-1,9 l / n'arọ. A na-echebara oghere dị n'ime oghere ụbụrụ, nke nwere ọnụego etu ihe si arụ ọrụ na - enweghị nchekwa na protein (20-30%). Penetrates site na ihe mgbochi placental. Ntinye uche na mmiri ara ara bu 25-60% nke ahụ na plasma.

A na-emegharị ya na imeju, ọkachasị n'okporo ụzọ epoxy na ịmalite nke metabolites ndị bụ isi: carbamazepine-10,11-epoxide na-adịghị arụ ọrụ na glucuronic acid. Isi isoenzyme nke na-enye biotransformation nke carbamazepine ka carbamazepine-10,11-epoxide bụ cytochrome P450 (CYP3A 4). N'ihi mmeghachi omume metabolic ndị a, etolite metabolite nke 9-hydroxymethyl-10-carbamoylacridane, nke nwere ọrụ ọgwụ na-adịghị ike.

Carbamazepine nwere ike itinye usoro metabolism nke ya. Ndi_1/2 mgbe nchịkwa ọnụ nke otu ọgwụ bụ awa 60-100 (na nkezi 70 awa), na nchịkwa ogologo oge nke T_1/2 mbelata n'ihi autoinduction nke sistem enzyme imeju. Mgbe otu mkpụrụokwu nke carbamazepine na-ejikwa ọnụ, 72% nke ọgwụ aepụrụ na-apụta na mmamịrị na 28% na feces, ebe ihe dị ka 2% nke ọgwụ ahụ na-adị na mmamịrị ahụ dịka carbamazepine na-agbanweghị, ihe dịka 1% n'ụdị metabolites 10.11-epoxy.

Enweghị ihe akaebe na ọgwụ ọgwụ nke carbamazepine na-agbanwe na ndị ọrịa agadi.

Na-egosi Finlepsin ard retard

Akwụkwụ na-adọ (mwepu ihe ọdịdọ na-enweghị isi (ewezuga ihe anaghị abịara ya), ụdị ịba n'ụba (obere ihe ọdịdọ).

trigeminal neuralgia,

idiopathic glossopharyngeal neuralgia,

ihe mgbu na ọnya nke nsogbu akwara ozi gbasara ọrịa shuga, ihe mgbu na neuropathy mamịrị,

Akwụkwụ na-adọ adọ na otutu sclerosis,

ihu akpa ọbara na trigeminal neuralgia,

ntụrụndụ nke tonic, ọrịa paroxysmal nke okwu na mmegharị (paroxysmal dysarthria na ataxia),

paroxysmal paresthesias na mgbu nke ihe mgbu,

ọrịa mmanya na-apụ apụ (ụjọ, mkparị, ikewapụ onwe ya, nsogbu ịrahụ ụra),

nkwarụ psychotic (ihe na - emetụta nsogbu na nsogbu schizoaffective, psychoses, aghara nke usoro limbic).

Mwepụta wepụtara ya na ihe mejupụtara

Finlepsin retard dị n'ụdị nke mbadamba ịhapụ oge dị ogologo: site na ọcha site na ntanji na-acha odo odo na-acha ọcha, ewepụghị, gbara gburugburu, a ga-etinye ọnụ nke mbadamba ihe ahụ, a na-etinye ihe nrịba nke nwere akụkụ n'akụkụ ọ bụla, 4 notches n'akụkụ akụkụ (iberibe 10 na blisters, na kaadiboodu ngwugwu nke 3, 4 ma ọ bụ 5 blisters).

Otu mbadamba 1 nwere:

• ihe na-arụ ọrụ: carbamazepine - 200 ma ọ bụ 400 mg,
• ihe inyeaka: triacetin, copolymer Eudragit RS30D methyl methacrylate, ethyl acrylate na trimethylammonioethyl methacrylate (1: 2: 0.1), copolymer Eudragit L30D-55 (ethyl acrylate, methaclates acid, sillololos cylo)

Ntuziaka maka iji Finlepsin retard: usoro na usoro onunu ogwu

Mpempe akwụkwọ finlepsin retard 200 mg ma ọ bụ mg mg 400 ka a na-ewere ọnụ site n'oge ma ọ bụ mgbe nri gasịrị ma jiri mmiri, mmiri ọ juiceụ orụ ma ọ bụ mmiri mmiri sachaa ya.

Ọ bụrụ na ọ dị mkpa, a ga-anabata mmachi nke ọgwụ a na mmiri mmiri, anaghị emebi ngwa ahịa ya.

A na-ekewa ụbọchị kwa ụbọchị gaa 1-2. Oke kachasị kwa ụbọchị bụ 1.6 g.

Na-atụ aro dosing kwa ụbọchị:

• ọgwụgwọ nke Akwụkwụ na-adọ. Ndị okenye: ọgwụ mbụ (otu ugboro, na mgbede) bụ 0.2-0.4 g, ekwesịrị ịbawanye dose ahụ ruo mgbe a ga - enweta ọgwụ na-enye nsonaazụ ọgwụgwọ kachasị mma na onye ọrịa. Ọkwa mmezi bụ 0.8-1.2 g. E kewara ya abụọ: 0.2-0.6 g n'ụtụtụ yana 0.4-0.6 g na mgbede. .Mụaka: usoro izizi maka ụmụaka 6-15 afọ (otu ugboro, na mgbede) - 0.2 g, a na-eji nwayọọ nwayọọ dobe ọgwụ (0.1 g kwa ụbọchị) iji nweta nsonaazụ kachasị mma. Thegwọ maka mmezi nke ụmụaka 6-10 gbara afọ bụ 0.4-0.6 g, a na-ekewa ya ka ọ dị ntụtụ 2 na nha dị: n'ụtụtụ - 0.2 g na mgbede - 0.2-0.4 g. ụmụaka gbara afọ 11-15 dị 0.6-1 g: n'ụtụtụ - 0.2-0.4 g, na mgbede - 0.4-0.6 g. Ogologo oge ọgwụgwọ na-adabere na ọnọdụ ụlọ ọrịa onye ọrịa na nnabata nke ọgwụ ahụ. . Echichara ọgwụ Finlepsin retard dị ka monotherapy. Ekwesịrị ịmalite iwebata ọgwụ ọgwụ ahụ n'ọgwụ ọgwụ antiepileptikị ejirila nwayọọ nwayọọ, ma ọ bụrụ na ọ dị mkpa, na-edozigharị ọnụọgụ nke ọgwụ ejikọtara ọnụ. Ọ bụrụ n’ịfughị ​​ọgwụ nke ọzọ, ị ga - ewere ya ma ọ bụrụ na ọ zaghị na otu oge nke ọgwụ abụọ. Dọkịta ahụ mere mkpebi iji nyefee onye ọrịa ahụ na ọgwụgwọ ọrịa Finlepsin retardps, oge eji ya ma ọ bụ ịkwụsị ọgwụgwọ ọgwụ n'otu n'otu. Ọ ga-ekwe omume belata ọgwụ ma ọ bụ kagbuo ọgwụ ahụ naanị na enweghịzu ihe ọdịdọ n'ime afọ 2-3. A kwụsịrị ọgwụgwọ maka afọ 1-2, jiri nwayọ belata dose ahụ n'okpuru njikwa electroencephalography. N’aka umuaka, tinyere mbelata nke ubochi obula, odi nkpa iburu n’onodu ibu ihe di n’iru,
• Akwụkwụ na-adọ ọdụ na-enwe otutu sclerosis: 0.2-0.4 g,
• trigeminal neuralgia na idiopathic glossopharyngeal neuralgia: usoro mbu bụ 0.2-0.4 g, egosiri ya rue mgbe ihe mgbu kwụsị kpamkpam. Maximumgwọ kachasị kwa ụbọchị bụ 0.8 g.Ihe a na-arụ na-abụkarị 0.4 g. Usoro izizi na ndị ọrịa mere agadi ma ọ bụ na-enwe mmetụta uche nke omume carbamazepine kwesịrị 0.2 g otu ugboro n'ụbọchị.
• ọrịa mgbu na neuropathy mamịrị: 0.2 g n'ụtụtụ na 0.4 g na mgbede. N'ọnọdụ ndị pụrụ iche, iji nweta ọgwụgwọ ọgwụgwọ, Finlepsin retard na-egosi n'ụtụtụ na mgbede na oke 0.6 g,
• ọgwụgwọ nke ị withdrawalụ mmanya na-egbu egbu na ọnọdụ ụlọ ọgwụ: na-abụkarị 0.6 g (0.2 g n'ụtụtụ na 0.4 g na mgbede), n'ọnọdụ ndị siri ike, 1.2 g na ụbọchị mbụ. Enwere ike ijikọ ọgwụ a na ọgwụ ndị ọzọ ejiri ọgwụgwọ iji kwụsị ị alcoholụ mmanya. Gaghi ejikota Finlepsin retard na ogwugwo na hypnotics. Ekwesịrị inwe nlezianya nyochara ọnọdụ uche nke onye ọrịa. Ọgwụgwọ kwesịrị ijikọ ya na nlele nke carbamazepine na plasma ọbara,
• psychoses (ọgwụgwọ na mgbochi): nha mbụ na mmezi bụ 0.2-0.4 g. Oke kachasị kwa ụbọchị bụ 0.8 g.

Ntụziaka pụrụ iche

Ogo mmetụta nke carbamazepine na mmepe nke ọrịa antipsychotic ọjọọ, ọkachasị mgbe ejikọtara ya na antipsychotics.

Mmepe nke mmetụta ndị sitere na sistemụ akwara etiti nwere ike ime ya site na ị relativeụ ọgwụ oke ma ọ bụ mgbanwe dị ukwuu na ọkwa nke carbamazepine na plasma ọbara.

Oge ịhapụ Finlepsin retard nwere ike ịme naanị ma ọ bụrụ na enyocha dọkịta oge niile maka ọnọdụ onye ọrịa.

Na-emegide usoro iji ọgwụ ahụ si dị, enwere ihe ize ndụ nke ịnwa igbu onwe ma ọ bụ ebumnuche, usoro a na-amaghị. Ekwesịrị ịgwa ndị ọrịa, ezinụlọ ha na ndị ọrụ banyere nke a na ha kwesịrị ịchọ nlekọta ahụike ozugbo ma ọ bụrụ na mgbaàmà nke omume igbu onwe ya.

Iji họrọ otu mbido na usoro mmezi nke na-eweta nsonaazụ kachasị mma, ọ bụ ihe amamihe dị na ya ịchọpụta ọkwa nke carbamazepine na plasma ọbara, ọkachasị mgbe edepụtara Finlepsin dị ka akụkụ nke ọgwụgwọ ngwakọta, n'ihi na site na ngwa ngwa metabolism na-ebute site na ntinye nke enzymes imeju microsomal ma ọ bụ mmekọrịta nke ọgwụ ndị a na-ejikarị eme ihe. a chọrọ dị iche iche na-atụ aro dose chọrọ.

Nwepu nke Finlepsin na mberede nwere ike ibute ọrịa Akwụkwụ, yabụ ọ bụrụ na ịchọrọ ịkwụsịtụ ọrịa onye ọrịa, ị ga-ebugharị na ọgwụ antiepileptik ọzọ n'okpuru mkpuchi nke intravenous (iv) ma ọ bụ njikwa njikwa diazepam, phenytoin (iv) ma ọ bụ ụzọ ndị ọzọ egosipụtara n'ọnọdụ ndị ahụ.

Iji ihe ọ alcoholụ alcoholụ na-aba n'anya megidere ihe ndabere nke iji ọgwụ a.

A na-eme mgbanwe maka ọgwụgwọ na carbamazepine site n'ibelata mbelata nke ọgwụ ndị mbụ a antiụrụ.

Womenmụ nwanyị mụrụ afọ ekwesịghị iji ọgwụ mgbochi nwoke a na-egbochi homonụ, ebe ọ bụ na anaghị enye afọ ime nke a pụrụ ịdabere na ya ma nwee ike ibute ọbara ọgbụgba oge.

Shouldgwọ ọgwụ ọnụ kwesịrị ijikọ ya na ileba anya n'ihe ndị na-egosi ọrụ imeju, ọkachasị ndị agadi na ndị ọrịa nwere ọrịa imeju. Site na mmepe nke ọrịa imeju siri ike, a ga-ewepụrịrị Finlepsin retard ozugbo.

Mgbe ị na-edepụta ọgwụ n'oge izu anọ mbụ nke ọgwụgwọ, kwa izu na mgbe ọ bụla kwa izu anọ, ọ dị mkpa iji duzie nnwale ọbara iji chọpụta ndị na-egosi ọnụọgụ platelet, reticulocytes, iron, urea na itinye uche nke electrolytes n'ọbara ọbara. Na mgbakwunye, nyocha urinal n'ozuzu, achọrọ electroencephalography.

Ekwesịrị ịkwụsị ọgwụgwọ maka leukopenia nwere mgbaàmà nke ọrịa na-efe efe ma ọ bụ leukopenia na-aga n'ihu.

Ọdịdị nke ahụ anụ ahụ dị nro n'ụdị ụdọ ma ọ bụ maculopapular nke dịpụrụ adịpụ adịkarịghị achọ iwepu Finlepsin retard, ihe mgbaàmà ahụ na-apụ n'anya nke onwe ha, gụnyere mgbe wedata ọgwụ ahụ. N'oge a, onye ọrịa chọrọ nlekọta nke dọkịta. Ọ bụrụ na ị na-enwe mmeghachi omume mmụọ, mgbaàmà nke ọrịa Stevens-Johnson syndrome ma ọ bụ ọrịa Lyell, ị kwesịrị ịkwụsị ị theụ mbadamba ndị ahụ.

Dọkịta kwesịrị ịgwa onye ọrịa banyere mmepe omume mmeghachi omume nsi, nziputa nke ihe ịrịba ama mmalite nke nwere ike ịba ahụ ọkụ, ọnya ọnya, akpịrị mgbu, ọnya ọnya ọnụ, ihe mgbu hematomas, ọbara ọgbụgba ma ọ bụ purpura. Maka nyocha nke oge a banyere mgbaàmà ndị a, ị ga-agbarịrị dọkịta.

Tupu ịmalite ọgwụgwọ, a na-atụ aro onye ọrịa ka ọ gaa nyocha nke ophthalmological, gụnyere mmuta mgbali intraocular na nyocha nke fundus. Site na nrụgide intraocular na-abawanye, a ga-enyocha ya mgbe ọ bụla na-ewere carbamazepine.

Na ọrịa dị egwu nke akwara obi, mmebi nke imeju na (ma ọ bụ) akụrụ, yana ndị mmadụ n’agadi, a na-atụ aro ka eji Finlepsin retard na doses dị ala.

Mkpebi mgbe nile oke larịị nke carbamazepine na plasma bụ ihe amamihe dị na ya ma ọ bụrụ na enwere enyo enyo maka mmetụ ọgwụ ya, onye ọrịa ahụ na-abawanye na ihe ọdịdọ ahụ, n’oge ime, n’ọgwọ ụmụaka, ya na ihe ịrịba ama nke mmeghachi omume nsi.

Mkparịta ụka ọgwụ ọjọọ

Site na nke Finlepsin retard:

• ndị na-egbochi iche iche nke isoenzyme CYP3A4: nwere ike inye aka na mmụba nke ọkwa carbamazepine na plasma ọbara na mmepe nke mmeghachi omume na-adịghị mma,
• ndị na - akpata CYP3A4 isoenzyme: nwere ike ime ka ọ bụrụ ihe na - eme ka metabolism nke carbamazepine belata ma belata nsonaazụ plasma na ọgwụgwọ ahụ. Agbanyeghị, mgbe a kagbuo, mmụba nke mkpokọ carbamazepine na-eme, ebe ọ bụ na ọnụego ya nke biotransformation na-ebelata,
• MA inhibitors: nwere ike ibute mmepe nke nsogbu ọgbụgba na oke ọbara, ọdụdọ, nwere ike igbu mmadụ, yabụ, oge dị n'etiti ihe ha na-eri kwesịrị ịdịkarịa ala izu abụọ.
• Nkwadebe lithium: na-eme ka mmụba na neurotoxic nke ọgwụ ọ bụla,
• verapamil, nicotinamide, diltiazem, desipramine, felodipine, danazole, dextropropoxyphene, acetazolamide, viloxazine, cimetidine, fluoxetine, fluvoxamine, macrolides - clarithromycin, josamycin, troleandomycin, erythuclezoina , propoxifene, ritonavir na ndị ọzọ na-egbochi nchebe maka ọgwụgwọ nke ọrịa nje immunodeficiency mmadụ: mee ka ịta ahụhụ nke carbamazepine dị na plasma ọbara, ya mere, nyochaa ọkwa nke carbamazepine na plasma Ntụzi nke usoro ntuziaka ya,
• valproic acid, primidone: ịchụpụ carbamazepine na njikọta na protein protein, nwere ike ime ka ịbawanye uru nke ọgwụ ọgwụ na-arụ ọrụ (carbamazepine-10,11-epoxide).
• phenobarbital, primidone, phenytoin, metsuximide, fensuximide, rifampicin, theophylline, cisplatin, doxorubicin, clonazepam, valpromide, oxcarbazepine, valproic acid, nkwadebe nke St John's wort perforated: nwere ike inye aka belata mkpokọta nke ọgwụ,
• felbamate: na - ebute mbelata nke ọkwa nke carbamazepine na mmụba nke ọdịnaya carbamazepine-10,11-epoxide na plasma ọbara, mbelata nke oge na mkpokọta ọbara ọbara na mmetụta nke felbamate ga - ekwe omume,
• isotretinoin: gbanwere bioavailability na (ma ọ bụ) mkpocha nke carbamazepine, carbamazepine-10,11-epoxide,
• phenothiazine, pimozide, thioxanthenes (chlorprotixen), molindone, haloperidol, maprotiline, clozapine, ọgwụ tricyclic: na-ebelata mmetụta anticonvulsant nke ọgwụ ahụ, na-abawanye mmetụta inhibitory na sistemụ na-ahụ maka etiti,
• clobazam, clonazepam, prednisone, digoxin, ethosuximide, prednisolone, valproic acid, prednisolone, alprazolam, dexamethasone, cyclosporine, methadone, doxycycline, haloperidol, theophylline, ọgwụ mgbochi ọnụ na estrorochenoric, oroferic, oroferic, oroferic, oroferic, oroferic, oroferic, oroferic, oroferic, oroferic, orofter, oroferic, orofter, orofter, orofter, orofter, orofter, oroferi, orofter, orofter, orofter, orofter, orofter, orofter, orom ), topiramate, lamotrigine, tricyclic antidepressants (amitriptyline, imipramine, clomipramine, northriptyline), clozapine, oxcarbazepine, tiagabin, ndị na-egbochi nchebe - indinavir, ritonavir na saquinavir, levothyroxine, b Ihe ndị a na-eme ka a na-eme ka a na-ahụ ihe ndị dị ka mkpụrụ osisi (fịlodine), midazolam, olanzapine, tramadol, praziquantel, risperidone, ziprasidone, itraconazole: belata ọkwa plasma na mmetụta ọgwụgwọ ha,
• tetracyclines: nwere ike ibelata ọgwụgwọ ọgwụgwọ carbamazepine,
• ọgwụ myelotoxic: na-eme ka ngosipụta hematotoxic mụbara nke carbamazepine,
• anticoagulants na-apụtakarị, mgbochi nke homonụ, folic acid, praziquantel: mee ka metabolism gị sie ike,
• paracetamol: na - eme ka metabolism ya na - eme ngwa ngwa, nke na - ebute mmụba nke nsonaazụ nsị na ọnya na mbelata ọgwụgwọ paracetamol,
• hydrochlorothiazide, furosemide (diuretics): na-enye aka na mmepe nke hyponatremia na ngosipụta nke ụlọ ọgwụ,
• pancronium na ihe ndị ọzọ na - adịghị eme ka ahụ dị jụụ: na-ebelata nsonaazụ ya, a chọrọ ndozi dose,
• homonụ thyroid: nwere ike ịkwalite ikpochapu,
• enflurane, halothane, fluorotan (ọgwụ mgbochi): mee ka metabolism gị dịkwuo nkọ, na-amụba ohere nke ịba ọcha n'anya.
• methoxyflurane: na-abawanye nguzobe nke nephrotoxic metabolites,
• isoniazid: na-akwalite mmetụta hepatotoxic ya,
• ethanol: na-aka njọ mmetụta ya.

Ihe analogues Finlepsin retard bu Finlepsin, Carbamazepine, Apo-Carbamazepine, Carbalepsin retard, Zagretol, Zeptol, Mazepin, Tegretol, Stazepin, Storilat.

Gịnị bụ Finlepsin Retard

Finlepsin, nke edere na radar dị ka Finlepsin retard, bụ nke ndị otu ọgwụ ọgwụ antiepileptik na-achịkwa mgbanwe ọnọdụ, na-ebe ihe mgbu, ihe mgbu na ngosipụta ndị ọzọ nke neuralgia. Ọgwụ mgbe mmalite nke nchịkwa nwere ọgwụ anticonvulsant, antidepressant, mmetụta analgesic.

Ndị nwere ọrịa neuralgic na-achọpụta na ihe mgbu ahụ belatara, ụjọ na-ebelata. Ngalaba Finlepsin nọ n'ọrụ na-enyere aka igbochi ọwa mmiri nke nwere sodium, na-eme ka akpụkpọ anụ nke ghara ịdị nro, na-ebelata synoptik nke mkpali, na -ebelata ohere nke ịmalite ma na-emekarị ihe ọdịdọ.

Aha mba ụwa na - abụghị ọgwụ nwere ọgwụ, ma ọ bụ INN - carbamazepine, bụ ihe ndị ọrụ Finlepsin na - arụ ọrụ. A na - eji ihe inyeaka:

• ntụ ntụ talcum
• ammonium methacrylate,
• stereta magnesium,
• crospovidone
• ihe eji eme ọla
• gelatin.

Mgbe nlekọta 1-2 gachara, a na-etinye carbamazepine n'ime ahụ, mgbe otu izu gasịkwara ịbara ọbara onye ọrịa ezuola maka ọgwụgwọ ọgwụgwọ. O nwere ikike ịbanye n'ime mgbochi Plas, yabụ a ga-eji Finlepsin kpachara anya mgbe a dị ime, jide n'aka na ị gakwuru ndị dọkịta.

Dị Mwepụta

Finlepsin dị n'ụdị nke mbadamba odo ma ọ bụ ọcha na-enwe mmetụta na-adịte aka, yana usoro nke 200 na 400 mg nke ihe na-arụ ọrụ. Ibe ọ bụla nwere iberibe iri. Ndị nwere obere usoro onunu ogwu ka ana enyere ndi umuaka na ndi mmadu oria nsogbu ha ka ha ghara ibute oria ojoo.

Mgbe agbatịchara ahụ ahụ, a na-abawanye ọnụọgụ ahụ na uche dọkịta na-ahụ maka onye ọrịa ahụ ruo mgbe ọ ga-arụpụta nsonaazụ achọrọ. A na-atụ aro ịnabata Finlepsin-400 ịmalite na mbadamba 0,5, na-enyocha ntuziaka nke ọma wee chọpụta ma ọ bụrụ na agwakọta ọgwụ na usoro ọgwụgwọ ndị ọzọ. N’ụlọ ahịa ọgwụ, a na-ere mbadamba Finlepsin n’ime igbe kaadi 3, 4, 5 blisters.

Usoro onunu ogwu na nhazi

Enweghị ntuziaka dọkịta gị akọwapụtara, usoro ọgwụ ndị a dị irè maka finlepsin 200 retard. Biko rube isi na usoro ọgwụgwọ dọkịta gị nyere, n'ihi na ma ọ bụrụ na Finlepsin 200 retard agaghị enwe mmetụta ọgwụgwọ!

Ego ole na ugboro ole ị ga-ewere Finlepsin 200 retard

Withgwọ ọrịa finlepsin 200 retard na-amalite nke ọma, na-edepụta ọgwụ ahụ na usoro onyonyo dị ala maka onye ọrịa ọ bụla, dabere na ụdị ọrịa ahụ. Mgbe ahụ, a ga-eji nwayọ were dose ahụ ruo mgbe ruru ihe nkwalite kachasị dị mma. Imalgwọ ọgwụ kachasị mma maka onye ọrịa, ọkachasị yana usoro ọgwụgwọ, ka ọkwa plasma kpebisiri ike. Dabere na ahụmịhe nke mkpokọ, ọgwụgwọ ịgwọ ọrịa finlepsin 200 retard na plasma bụ 4-12 μg / ml.

Jiri dochie 200 retardpsin dochie ọgwụ antiepileptik iji nwayọ nwayọ mee ya, na -ebelata usoro nke ọgwụ a na-ejibu. Ọ bụrụ na ọ ga - ekwe omume, a na - eji ọgwụ antiepileptik naanị maka monotherapy. Ọ bụ dọkịta ọkachamara na-ahụ maka usoro ọgwụgwọ ya.

Onu ogwu a na-anabatakarị bụ 400-1200 mg nke finlepsin 200 retards kwa ụbọchị, nke kewara n'ime 1-2 usoro kwa ụbọchị. Ceedgabiga ngụkọta kwa ụbọchị nke 1200 mg anaghị eme uche. Oke kachasị kwa ụbọchị ekwesịghị ịgabiga 1600 mg, n'ihi na usoro onyonyo dị elu nwere ike ịbawanye ọnụ ọgụgụ nke mmetụta.

N'ọnọdụ ụfọdụ, dose achọrọ maka ọgwụgwọ nwere ike ịhapụ ụzọ dị iche iche a tụrụ aro ya na usoro mmezi, dịka ọmụmaatụ, si mee ka metabolism na-agba ngwa ngwa n'ihi ntinye nke enzymes imeju microsomal ma ọ bụ n'ihi mmekọrịta dị n'etiti ọgwụ.

Enweghị ntuziaka pụrụ iche sitere na dọkịta, ha na-eduzi ụkpụrụ ndị na-esonụ nke usoro iji ọgwụ ọjọọ:

Ọgwụ anticonvulsant

Na mkpokọta, na ndị okenye, mbadamba 1-2 nke mbadamba carardama (nke kwekọrọ na 200 -400 mg nke carbamazepine) na-eji nwayọ nwayọ elu na mmezi nke mbadamba mkpụrụ osisi 4-6 nke (nke kwekọrọ na 800-1200 mg nke carbamazepine).

Na mkpokọta, mmezi nke carbamazepine maka ụmụaka na-eme ka ahụ ha dị ogo 10-20 mg / kg kwa ụbọchị.

A na-atụ aro usoro nhazi dosing ndị a.

A na-enye ndị okenye iwu n'ụtụtụ / mgbede200-300 mg na mgbede 200-600 mg 400-600 mg Edebere ụmụakalee ndetu site na afọ isii ruo afọ iri n’uhuruchi150-200 mg na mgbede200 mg n'ụtụtụ 200-400 mg 11 ruo 15 afọ ụtụtụ / mgbede150-200 mg na mgbede200-400 mg 400-600 mg

Maka ụmụaka na-erubeghị afọ isii, maka mmalite na nkwado nkwado, mbadamba ihe ndị na-adịghị agbatị oge dị. N'ihi ahụmịhe ezughị ezu nke e nwetara na mbadamba retard, anaghị atụ aro maka ụmụaka n’oge a.

Mgbochi mmepe nke ihe ọdịdọ nwere ọrịa ndọrọ ndọrọ mmanya na-egbu egbu n’ụlọ ọgwụ

Ọkara nke kwa ụbọchị bụ 1 mbadamba ihe retard n'ụtụtụ, na mgbede, mbadamba mbadamba 2 ka edepụtara (nke kwekọrọ na 600 mg nke carbamazepine). N'okwu ndị siri ike, na ụbọchị mbụ, enwere ike ịbawanye ọgwụ ahụ gaa mbadamba 3 nke retard ugboro abụọ n'ụbọchị (kwekọrọ na 1200 mg nke carbamazepine).

Ekwesighi ijikọ Finlepsin 200 retard na ọgwụ ogwugwo. N'ikwekọ chọrọ ọgwụ, agbanyeghị, ọ bụrụ na ọ dị mkpa, enwere ike ijikọ finlepsin 200 retard na ihe ndị ọzọ ejiri na-emeso ịbelata mmanya.

N'oge ọgwụgwọ, ọ dị mkpa ileba anya mgbe niile ọdịnaya nke finlepsin 200 retards na plasma ọbara.

N'akụkụ mmepe nke mmetụta ndị sitere na sistemụ akwara na akwara onwe ya (lee ihe ịtụnanya nke ị withdrawalụbiga mmanya ókè na ngalaba “Mmetụta nsonaazụ”), a na-ehiwe nlezianya nyocha ụlọ ọgwụ maka ndị ọrịa.

Trigeminal neuralgia, ezigbo glossopharyngeal neuralgia

Mkpụrụ mbụ eburu bụ 1-2 mbadamba ihe ochie (nke kwekọrọ na 200 - 400 mg nke carbamazepine), nke, rue mgbe mgbu ahụ ga-apụ n'anya, na-abawanye site na mbadamba mkpụrụ ọgwụ abụọ nke azụ (kwekọrọ na 400-800 mg nke carbamazepine), nke na-ekesa na 1-2 otu doses na ụbọchị. Mgbe nke ahụ gasị, n'otu akụkụ nke ndị ọrịa, enwere ike ịga n'ihu na usoro ọgwụgwọ dị ala, nke nwere ike igbochi mwakpo ihe mgbu nke 1 mbadamba ihe nkwụghachi ugboro abụọ n'ụbọchị (kwekọrọ na 400 mg nke carbamazepine).

Maka ndị ọrịa na-arịa ọrịa na-eme agadi ma na-enwe mmetụta, a na-edenye finardpsin 200 retard na mbido 1 mbadamba ihe azụ otu ugboro n'ụbọchị (kwekọrọ na 200 mg nke carbamazepine).

Mgbu na neuropathy mamịrị

Ihe nkezi ubochi ubochi bu 1 mbadamba ihe n'ụtụtụ na mbadamba mbadamba 2 na mgbede (nke kwekọrọ na 600 mg nke carbamazepine). N'ọnọdụ ndị pụrụ iche, enwere ike ịkọwa finlepsin 200 retard na mbadamba 3 nke retard ugboro abụọ kwa ụbọchị (nke kwekọrọ na 1200 mg nke carbamazepine).

Akwụkwụ na-adọ adọ n'ime otutu sclerosis

Nkezi ubochi ubochi bu 1-2 retard mbadamba ugboro abuo na ubochi (ihe dika 400-800 mg nke carbamazepine).

Ọgwụgwọ na mgbochi nke psychosis

Ọgwụ nke mbụ, nke na-ezukwa ike ka ọ bụrụ ihe eji arụ ọrụ, bụ 1-2 mbadamba mbadamba ụbọchi kwa ụbọchị (nke kwekọrọ na 200 -400 mg nke carbamazepine). Ọ bụrụ na ọ dị mkpa, a ga-abawanye ọgwụ a na mbadamba 2 nke retard ugboro abụọ kwa ụbọchị (nke kwekọrọ na 800 mg nke carbamazepine).

Ndị ọrịa nwere ajọ ọrịa obi, mmebi imeju na akụrụ, yana ndị agadi ka edepụtara ọgwụ oke.

Kedụ mgbe ị ga - ewere 200 retardpsin

Mbadamba mbadamba anaghị ejide ya, a na-ewere ya n’oge ma ọ bụ mgbe nri gachara, were were mmiri hichaa ha zuru ezu (dịka ọmụmaatụ, otu iko mmiri).

Enwere ike iwere mbadamba azụ azụ mgbe nkwarụ mbu ha dị na mmiri (n'ụdị nkwusioru). Mgbatị ahụ ga-adịgide adịgide mgbe mbadamba mbadara na mmiri.

N'ọnọdụ ụfọdụ, nkesa nke ọgwụ kwa ụbọchị ruo 4-5 otu usoro kwa ụbọchị wee bụrụ nke kachasị arụ ọrụ. Maka nke a, ụdị usoro ịsụ ọgwụ nke ime ihe na-adịghị agbatị agbatị kachasị mma.

Ogologo oge ole ka ị ga-ewere finlepsin 200 retard

Ogologo oge eji na-adabere na ngosipụta na nzaghachi nke onye ọrịa na ọgwụ ahụ.

Akwụkwụkwụ na-agwọ ọrịa ogologo oge. Dọkịta ọkachamara kwesịrị ikpebi n’ibugharị onye ọrịa na ọrịa finardpsin 200, oge ọ ga-eji na kagbuo ya n’otu n’otu. Na mkpokọta, ịnwere ike ịnwa belata ọgwụ nke ọgwụ ahụ ma ọ bụ kwụsị kpamkpam ọgwụgwọ ahụ tupu oge ịhapụ ọdịdọ afọ 2-3.

A na-akwụsị ọgwụgwọ site na mbelata nke ị theụ ọgwụ ahụ ruo afọ 1-2. N'okwu a, ụmụaka kwesịrị iburu n'uche mmụba nke anụ ahụ. Ihe ngosi EEG ekwesighi ibelata.

Na ọgwụgwọ nke neuralgia, ọ bara uru ịkọwa finlepsin 200 retard na usoro mmezi, ezuru iji belata ihe mgbu, ruo ọtụtụ izu. Site n'iji nwayọ belata dose ahụ, ọ dị mkpa iji chọpụta ma ọ bụrụ na mgbaghara nke ọrịa ahụ na-enweghị oge. Site na ịmalite iwere ihe mgbu, a na-aga n'ihu na usoro a na -emezi ya.

Ogologo oge ọgwụgwọ maka mgbu na neuropathy mamịrị na ọrịa ọdịdọ na otutu sclerosis bụ otu ihe ahụ maka neuralgia.

Ọgwụ nke nkwụghachi mmanya na finlepsin 200 retard na-akwụsị site na iji nwayọ nwayọ na-eme ihe karịrị ụbọchị 7-10.

A na-eme mgbochi nke manic-ịda mba ogologo oge.

Njehie na iji ogwu na ị overụbiga mmanya ókè

Ọ bụrụ na echefuru iji otu ọgwụ were, mgbe ọ bụla ị chọpụtara ya, were ya ozugbo. Ọ bụrụ na mgbe nke a gasịrị, ị ga-a theụ ọgwụ ọzọ a kapịrị ọnụ, mgbe ahụ ị ga-agafe ya, mgbe nke ahụ gasịkwara ọzọ ịbanye na usoro usoro ọgwụgwọ gị ziri ezi. N'ọnọdụ ọ bụla, mgbe otu echezọ echefuru, ewerela okpukpu abụọ nke finlepsin 200 retard. Inwe obi abụọ, biko kpọtụrụ onye na-ahụ maka ahụike gị maka enyemaka!

Ihe ichoro ichebara echiche ma oburu ikwusi igba ya ma obu kpoo ya oge

Gbanwe dose ahụ n'onwe gị ma ọ bụ ọbụna ịkwụsị ọgwụ ahụ na-enweghị nlekọta ahụike dị ize ndụ! N'okwu a, mgbaàmà nke ọrịa gị nwere ike ịka njọ ọzọ. Tupu ikwusi iburu finlepsin 200 laghachi azu, ị ga-agakwuru dọkịta gị banyere nke a.

Ihe ị ga - eme ma ọ bụrụ na ewere Finlepsin 200 retard na ọnụ ọgụgụ buru ibu

Dodoụ ọgwụ ọ drugụ requiresụ chọrọ ọgwụ ọgwụ maka enyemaka. A na-egosipụta onyonyo karịrị akarị nke finlepsin 200 retard na-enwe nsonaazụ ya, dị ka ịma jijiji (ịma jijiji), ihe ọdịdọ na-eme mgbe ụbụrụ nwere obi ụtọ (ọnya ụfụ na-akụ ụfụ), oke iwe, yana iku ume yana ọrụ akwara mgbe ana-ebelata (oge ụfọdụ buliekwa elu) ọbara mgbali elu, mgbali obi (tachycardia) na ọgba aghara na mkpachapụ anya na obi (ngọngọ atara, mgbanwe ECG), nsụhọ uche ruo. akụkụ okuku ume na njide na gbasara obi njide. N'ọnọdụ ndị dịpụrụ adịpụ, a hụrụ leukocytosis, leukopenia, neutropenia, glucosuria ma ọ bụ acetonuria, bụ nke ndị gosipụtara na-egosi nyocha ụlọ nyocha.

Enweghị ọgwụ mgbochi akọwapụtara maka ọgwụgwọ nke oke nsị na finlepsin 200 retard. Treatmentgwọ ọrịa overleses nke finlepsin 200 retards, dịka iwu, a na-arụ ọrụ dabere na ngosipụta mgbu na-egbu mgbu n'ụlọ ọgwụ.

Nsonaazụ ndị a hụrụ na-abụkarị na usoro ọgwụgwọ ejikọtara karịa nke monotherapy. Dabere na dose na tumadi na mmalite ọgwụgwọ, mmetụta ndị na-esonụ nwere ike ime:

Sistemụ Uche Central / Mind

Ọnọdụ nke mmụọ, mmụọ ịmachaghị anya (ihi ụra), nkụda mmụọ, ike ọgwụgwụ, isi ọwụwa na ngaghari (cerebellar ataxia) na isi ọwụwa nwere ike ime. Ndị ọrịa agadi nwere ike ịmalite ọgba aghara na ụjọ.

N'ọnọdụ ndị dịpụrụ adịpụ, a na-ahụ ọnọdụ obi ọjọọ, omume obi ọjọọ, ike ọgwụgwụ nke echiche, enweghị ebumnobi, yana ọgba aghara n'echiche (hallucinations) na tinnitus. Mgbe ị na-eji finlepsin 200 retard eme ihe, enwere ike ịgbatị mmụọ latent.

Mmeghari ahụ na - adịkarịghị adị, dị ka akwa ahụ na - eme mkpọtụ, mmerụ ahụ, ma ọ bụ ịgbado anya (nystagmus). Na mgbakwunye, na ndị ọrịa agadi na ụbụrụ ọnya, nsogbu nke ọrụ ịhazi, nwere ike ime, dịka mmegharị nke nnabata na mpaghara Rotolitic n'ụdị mmekpa ahụ (rotolitic dyskinesias), mmegharị ngagharị (choreoathetosis). Ufodi nsogbu nke ikwu okwu, inwe mmetụta ụgha, adịghị ike akwara, mkparị akwara (akụkụ neuritis) yana ngosipụta nke mkpịsị ụkwụ ukwu (paresis) na nsogbu nghọta.

Ọtụtụ n'ime ihe ịtụnanya ndị a na-apụ n'anya nke onwe ha mgbe ụbọchị 8-14 gachara ma ọ bụ mgbe ha selatara obere oge. Ya mere, ọ bụrụ na ọ ga-ekwe omume, a na-eji nlezianya dozie finlepsin 200, na-amalite ọgwụgwọ site na obere usoro, wee jiri nwayọọ nwayọọ mụbaa ha.

Anya

N'ụfọdụ oge, enwere ọgbụgba nke anya na-ahụ anya (conjunctivitis), oge ụfọdụ ọsịsịsịsịsịsịsịsịsịsịsịsịsịsịsị ọgba ntị (adịghị anya nke anya, anya abụọ, ọhụhụ). Achọpụtala nsogbu igwe ojii.

N'ime ndị ọrịa nwere glaucoma, ọ dị mkpa ịcheta nrụgide intraocular mgbe niile.

Sistemụ arụmọrụ

N'ọnọdụ ndị dịpụrụ adịpụ, a hụrụ ihe mgbu na nkwonkwo na akwara (arthralgia, myalgia) yana yana spasms muscle. Ihe ịtụnanya ndị a kwụsịrị mgbe ekpochapụ ọgwụ.

Akpụkpọ ahụ na akpụkpọ anụ mucous

A kọwo ọrịa nke mmeghachi omume nfụkasị anụ ahụ na ma ọ bụ na-enweghị ahụ ọkụ, dị ka urticaria na-adịghị ahụkebe ma ọ bụ nke na-eme ugboro ugboro, itching, mgbe ụfọdụ nnukwu efere ma ọ bụ akpịrị anụ ahụ (exfoliative dermatitis, erythroderma), necrosis nke elu akpụkpọ ahụ na ọnya na-arịa (syndrome). Lyell), fotoensitivity (photoensitivity), ọbara ọbara nke akpukpo aru nke polymorphic rashes n'ụdị tụrụ na etolite ọnụ, ya na ọbara ọgbụgba (exudative erythema multiforme, erythema nodosum, Stevens syndrome) Johnson), petechial hemorrhages na anụ ahụ, na systemic lupus erythematosus (lupus erythematosus akwadebe).

N'ọnọdụ ndị dịpụrụ adịpụ ma ọ bụ nke a na-adịghị ahụkebe, arịba ama ntutu (alopecia) na sweating (diaphoresis).

Sistem na okirikiri

N'ihe banyere mmeghachi omume hypersensitivity na ọgwụgwọ finlepsin 200 retard, na mgbakwunye, nsogbu eserese ọbara na-esote nwere ike ime: adịkarịghị ma ọ bụ na-abawanye (leukocytosis, eosinophilia) ma ọ bụ ibelata (leukopenia) na ọnụọgụ leukocytes ma ọ bụ platelet (thrombocytopenia) na oke mbibi. Dabere na akwụkwọ ndị ahụ, ụdị leukopenia na-adịkarị na-apụta (dị mkpụmkpụ n'ihe dị ka 10% nke ikpe, yana ịnọgidesi ike na 2% nke okwu).

Kọrọ akụkọ dịpụrụ adịpụ nke ọrịa ọbara, mgbe ụfọdụ ọ na-eyi ndụ egwu, dịka agranulocytosis, ọrịa aklastic, yana ụdị ọbara ọgbụgba (hemolytic, megaloblastic), yana mmụba nke oghere na akwara.

Site na nchapu nke leukopenia (nke na-abụkarị neutropenia), thrombocytopenia, rashes skin skin (exanthema) na fever finlepsin 200 retards na-kagbuo.

Ọkpụkpụ afọ

Mgbe ụfọdụ enweghị agụụ, akpa nkụ, ọgbụgbọ na ọgbụgbọ, afọ ọsịsa ma ọ bụ afọ ntachi na-apụtakarị. Ekpesarala ikpere mgbu na mbufụt nke mucous nke oghere oropharynx (stomatitis, gingivitis, glossitis). Ihe omume ndi a na-agabiga onwe ha mgbe ubochi 8-14 nke ọgwụgwọ ma obu mgbe ha wedata obere ogwu ahu. Enwere ike ịhapụ ha site na nhọpụta mbụ nke ọgwụ dị ala yana mmụba ha na-eji nwayọọ nwayọọ.

Enwere ihe ngosi na akwukwo a nke carbamazepine nwere ike ibute mbufụt nke pancreas (pancreatitis) oge ufodu.

Imeju na bile

Mgbe ụfọdụ mgbanwe na-egosi na nyocha imeju na-arụ ọrụ, na obere ọrịa jaundice pụtara; n'ọnọdụ ụfọdụ, ụdị ọrịa ịba ọcha n'anya (cholestatic, hepatocellular, granulomatous, mix) na-apụta.

A kọwapụtala ọnọdụ abụọ nke nnukwu nsogbu ọgụ nla.

Hormonal, mmiri na metabolism metabolism

Ekpesarala ikpe ndị metụtara mmụba ara na ụmụ nwoke (gynecomastia) na mmiri ara na-asọ site na gm mammary na ụmụ nwanyị (galactorrhea).

Finlepsin 200 retard nwere ike imetụta usoro ọrụ thyroid (triiodothyronine, thyroxine, homonụ na-akpali akpali na thyroxine n'efu), ọkachasị mgbe ejikọtara ya na ọgwụ mgbochi ọgwụ ndị ọzọ.

N'ihi ọrụ nke finlepsin 200 retard, nke na-ebelata mmamịrị ahụ n'ahụ (mmetụta antidiuretic), n'ọnọdụ ndị dịkarịsịrị, enwere ike ịhụbelata mbelata sodium (hyponatremia), yana ọgbụgbọ, isi ọwụwa na ọgba aghara.

A hụrụ ihe dị iche iche na-egosi edema na mmụba nke ahụ. Finlepsin 200 Retard nwere ike belata ọkwa calcium. N'ọnọdụ ndị dịpụrụ adịpụ, nke a na-eduga n'ibe ọkpụkpụ (osteomalacia).

Akụkụ akụkụ akụkụ akụkụ iku ume

Ekpesara ụfọdụ maka mmeghachi omume nke ịmị mkpụrụ nke ngụgụ na ọgwụ, yana ọkụ, mkpụmkpụ ume (dyspnea), oyi baa na ụkwara ume ọkụ, wee kọwaa.

Ọkpụkpụ mkpụrụ ndụ

Ọ na-adịkarị ọrụ na-arụ ọrụ akụrụngwa, nke gosipụtara na ụba protein na mmamịrị (proteinuria), ọdịdị ọbara na mmamịrị (hematuria), belatara mmịpụta mmamịrị (oliguria), n'ọnọdụ ndị obere, ha etolite etolite akụrụ. Ikekwe nsogbu ndị a bụ n'ihi mmetụta antidiuretic intrinsic nke ọgwụ. Mgbe ụfọdụ dysuria, pollakiuria na njide urinary na-apụta.

Na mgbakwunye, enwere ọnọdụ ndị metụtara mmekọahụ, dị ka enweghi ike na agụụ mmekọahụ.

Ọkpụkpụ akụrụngwa

N’ebe ndị a na-adịghị ahụkebe ma ọ bụ ndị dịpụrụ adịpụ, ọkachasị n’ebe ndị agadi ma ọ bụ n’arụrụ ndị nwere ọrịa obi, obi obi dị ala (bradycardia), nsogbu obi, na-akawanye njọ n’ọrịa obi obi.

Oge ụfọdụ, enwere mmebi nke mkpachapụ obi n'obi (mgbochi ọnụnọ), n'ọnọdụ ndị dịpụrụ adịpụ yana mgbakasị ahụ. Na mgbakwunye, n’ọnọdụ ụfọdụ, ọbara mgbali na-ebelata ma ọ bụ na-ebili. Ndalata ọbara mgbali elu na-ebuputara na iji ọgwụ eme ihe na oke doses.

Na mgbakwunye, vasculitis, thrombophlebitis, na thromboembolism hụrụ.

Mmeghachi omume hypersensitivity

Mmeghachi nke oge nke hypersensitivity na ọgwụ adịghị adịkarị, na-eme ahụ ọkụ, ọnya anụ ahụ, ọnya afọ, mbufụt ụdọ, olu mgbu, ọnụ ọgụgụ mkpụrụ ndụ na-acha ọcha na -akpata ọbara, imeju na ọnya mụbara, yana mgbanwe mgbanwe usoro ule imeju nke nwere ike ime na ọnọdụ dị iche iche. ngụkọta, tinyekwa akụkụ ahụ ndị ọzọ na usoro ahụ, dịka ngụgụ, akụrụ, pancreas na myocardium.

N'ọnọdụ ndị dịpụrụ adịpụ, a hụrụ nnukwu mmeghachi omume dị ukwuu na mbufụt nke meninges na myoclonus na eosinophilia.

Ọ bụrụ n’ịchọpụta nsonaazụ na-ekwughi aha na nkọwapụta a, biko gwa dọkịta gị ma ọ bụ onye na-ere ọgwụ banyere nke a.

Kedu ihe ndị aga-ewere n ’mmetụta ọ bụla

Ọ bụrụ n’ịchọpụta nsonaazụ ndị a kpọtụrụ aha n’elu, gwazie dọkịta gị ozugbo onye ga-ekpebi ike ha ma mee ihe iji lụso ha ọgụ (leekwa ngalaba “ịkpachara anya maka ojiji)”. Karịsịa mgbe enwere ọnya, ọnya mgbu, mmeghachi omume anụ ahụ na-adịghị mma na ụdị rashes na-enwewanye ọnya ọbara na / ma ọ bụ ihe mgbaàmà na-egbu mgbu n'oge ọgwụgwọ finlepsin 200 retards, ị kwesịrị ịkpọtụrụ dọkịta ozugbo ma nyochaa foto ọbara.

Site na mmepe nke mmeghachi omume nfụkasị ahụ siri ike, finlepsin 200 retard na-akwụsị ozugbo.

Ọ bụrụ na mgbanwe ụfọdụ n’ihe onyonyo ọbara pụtara (leukopenia, nke na-abụkarị neutropenia, thrombocytopenia), akpịrị anụ ahụ (exanthema) na fever finlepsin 200 retards na-akagbu.

Ọ bụrụ n ’ihe mgbaàmà nke mmebi imeju ma ọ bụ nke nwere nsogbu, dịka ụdọ, enweghị agụụ, ọgbụgbọ, ụcha acha odo odo ma ọ bụ imeju imeju, gakwuru dọkịta ozugbo.

Irationbọchị mmebi ọgwụ ọjọọ

Afọ 3
E gosipụtara na nchekwa nke mbadamba ihe nkwụghachi na mbadamba ngwugwu ọnya na igbe kaadi.
Mgbe oge akọwapụtara, ejila mbadamba ihe ochie ọzọ nke ngwugwu a.

A na-edebe ọgwụ iji ghara iru ụmụaka!

Finlepsin 200 retard na-abia na mkpuchi umuaka nwere nchekwa mkpuchi siri ike. Bụrụ na ọ ga-esiri gị ike ịpị mbadamba ihe retard, yabụ tupu ime nke a, anyị na-adụ gị ọdụ ka ị jiri obere ihe kpuchie kpuchie ya.

Ọnọdụ nchekwa

A na-echekwa ọgwụ a n'ọnọdụ nkịtị.

Dị Mwepụta

Finlepsin 200 retard dị na ngwugwu 50, 100, na mbadamba mbadamba 200.

Ime na lactation

Mgbe ọ bụla enwere ike, a na-enye Finlepsin ® retard ndị nwanyị oge ọmụmụ dịka monotherapy, na obere oge, Ugboro ugboro nke mmerụ ịmụ nwa site n'aka ndị nne bụ ndị jikọtara ọgwụ antiepileptik karịrị nke monotherapy.

Mgbe ime dị, ọ dị mkpa ịtụle uru a tụrụ anya na ọgwụgwọ na nsogbu ndị ọ ga-ekwe omume, ọkachasị n'oge ọnwa atọ mbụ nke ịtụrụ ime.

A maara na ụmụaka ndị nne na-arịa akwụkwụ na-enwe nsogbu intrauterine na-eto eto, gụnyere mmejọ. Finlepsin ardard nwere ike iwelite ohere nke nsogbu ndị a. Enwere akụkọ dịpụrụ adịpụ nke ọrịa nke agbụrụ na arụrụ arụ, gụnyere enweghị mmechi nke akụkụ ụdọ vertebral. (spina bifida). Ọgwụ Antiepileptic na-abawanye ụkọ folic acid, nke a na-ahụkarị n’oge afọ ime, nke nwere ike ime ka mmerụ ahụ dị n’ọbara pụta n’ahụ ụmụaka, yabụ na-atụ aro ị takingụ folic acid n’ihu ịtụrụ ime na n’oge ime. Iji gbochie nsogbu ọbara ọgbụgba n'ime ụmụ amụrụ ọhụrụ, a na-atụ aro ka ndị ụmụ nwanyị n’izu ikpeazụ nke afọ ime, yana ụmụ amụrụ ọhụrụ, ka ha depụta vitamin K.

Carbamazepine na-abanye n'ime mmiri ara, yabụ uru na mmetụta ndị ọ na-agaghị ekwe omume nke ị breastụ ara kwesịrị iji ya tụnyere usoro ọgwụgwọ na-aga n'ihu. Site n’ịnọgide na-a breastụ ara mgbe ị na-a theụ ọgwụ ahụ, ịkwesịrị igosipụta nlezianya maka nwatakịrị ahụ na o nwere ike ịmalite mmeghachi omume ọjọọ (dịka ọmụmaatụ, ụra ụra siri ike, mmeghachi ahụ anụ ahụ).

Emeputa

Teva Operations Poland Sp. z oo, st. Mogilska 80, 31-564 Krakow, Poland.

Aha ndi enyere n'iwu n’aha nke enyere n’enye aha akwukwo ha. Teva Pharmaceutical Enterprises Ltd., Israel.

Ekwesịrị izipu ndị na-azụ ahịa na adreesị: 115054, Moscow, ul. Gross, 35.

Ekwentị: (495) 644-22-34, faksị: (495) 644-22-35 / 36.

Ntuziaka maka iji Finlepsin retard

Dịka ntuziaka ahụ si dị, ịdị irè nke ọgwụ adịghị n'ụzọ ejikọtara ya na oriri, yabụ ị nwere ike ị drinkụ ya n'oge ọ bụla. Maka ọgwụgwọ nke Akwụkwụ na-adọ, a na-eji Finlepsin dị ka monotherapy, na-ejikọghị ọgwụ ndị ọzọ. E jiri nlezianya gbakọọ usoro ahụ maka afọ dị iche iche, na-amalite site na nke kacha nta ma jiri nwayọọ nwayọọ na-abawanye. Dịka ntuziaka maka ndị okenye si dị, a na-eji usoro ọgwụgwọ kwa ụbọchị:

• mbido - 200-400 mg,
• ọgwụgwọ ma ọ bụ nkwado - 800-1200 mg,
• ihe kachasị bụ 1600-2000 mg.

Ọnụ ego nke carbamazepine bụ nke ọ bụla maka mmadụ ọ bụla, ọ kewara ụzọ atọ. Ọ bụrụ na onye ọrịa ahụ enweghị ọgwụ ọfụma na ebumnuche ọ bụla, ị gaghị a twoụ mmanya abụọ otu oge iji zere ịdoụbiga mmanya ókè. Na usoro ọgwụgwọ ụmụaka, kwa ụbọchị na-adabere na afọ, nke nta nke nta ọ na-abawanye site na 100 mg ruo mgbe arụpụta ihe achọrọ:

• 1-5 afọ - 100-200 ruo 400 mg,
• Afọ 6-10 - 200-300 ruo 600 mg,
• Afọ 11-15 - 300-400 ruo 1000 mg.

Dọkịta ga-ahazi oge ọ ga-ewere Finlepsin, na-elekwasị anya n'ọdịmma onye ọrịa. N'ọnọdụ ụfọdụ, ọ na-ewe ọtụtụ afọ ka ọgụ ahụ kwụsị. A na -ebelata usoro onunu ogwu mgbe usoro ọgwụgwọ gara nke ọma na enweghị ọdịdọ ruo afọ 2-3. Thezọ kachasị mma iji nwalee ịdị mma nke ọgwụgwọ Finlepsin bụ ịnwe electroencephalogram nke ụbụrụ.

Ọnụ ego Finlepsin retard

Mgbe emesịrị dọkịta, ịkwesịrị ịzụta ụdị ọgwụ dị mma ma bido ị itụ ya. Ihe dị iche na ọnụahịa maka Finlepsin na St. Petersburg na Moscow na-adabere na ọnụ ọgụgụ mbadamba, nkwakọ ngwaahịa, usoro onunu ogwu.

Finlepsin-200, 50 PC.

Finlepsin-400, 30 PC.

Finlepsin-400, 50 PC.

Na Russia, ire ndị Finlepsin retard na-arụ ọrụ n'aka onye na-emepụta Poland TEVA. Mgbe ọgwụ adabaraghị onye ọrịa, dọkịta nwere ike ịhọrọ otu n'ime analogues Finlepsin. Ogwu nwere ihe ndi ozo mejuputara, ha nwere otu ihe. Analogs, n'adịghị ka nke mbụ, dị ọnụ ala, mana enwere mmetụta ndị ọzọ, yabụ akwadoghị dochie Finlepsin n'onwe gị.

Ndepụta nke ọgwụ antiepileptik gụnyere:

Regina, dị afọ 53. A Iụrụ m Finlepsin ruo ọnwa 2, mgbe otu dọkịta depụtara m ya mgbe ọnyá nke trigeminal akwara. A dọrọ m aka ná ntị na ọgwụ ahụ nwere ọtụtụ nsonaazụ, ya mere amalitere m ị halfụ ọkara mbadamba na mbụ. Ọ bụ na ọ gaghị ekwe omume izere ihe na-adịghị mma kpamkpam - n'ụtụtụ ụtụtụ, enwere m ntakịrị nkụchi, mana Finlepsin nyeere m aka.

Julia, dị afọ 35. Site na enyemaka nke Finlepsin a, m gwọrọ ọrịa akwụkwụ na nwatakịrị. Mbadamba mbadamba ahụ nọ na syrup. Ọ dị m mkpa ịnagide iro ụra na obere ọgbụgbọ, mana ruo otu afọ nnabata n'okpuru nlekọta nke ọkachamara, anyị jisiri ike zere ọdụdọ na-egbu egbu. Anyị nwara ịgbanye ọgwụ yiri nke ahụ, nke dị iche na ọnụego ya, mana ya adaghị.

Eugene, 47 dị afọ jiri Finlepsin maka ịda mba na ndụmọdụ nke onye isi mgbaka. Edere m iwu ịzụta ụlọ ahịa n'ịntanetị na iji nnyefe zigara ya. N’egota ego, ọ tụghị ọnụ ọnụ. Dọkịta dọrọ m aka ná ntị ka m ghara ijikọ Finlepsin na mmanya, ma ọ bụghị ya, mmetụta ndị ọzọ ga-aka njọ karịa akọwara ha na nchịkọta ọgwụ. Anaghị m akwado ị drinkingụ ọgwụ na-enweghị ndenye ọgwụ.